Hong Kong, 26 June 2026—CF PharmTech, Inc. announced an updated roster of 11 board members and detailed the latest committee assignments.

The board comprises: • 5 Executive Directors – chaired by Dr. Liang Bill Wenqing • 2 Non-executive Directors • 4 Independent Non-executive Directors

Independent directors now represent 36.36% of the board, meeting typical Hong Kong listing governance norms.

Committee structure 1. Audit Committee • Chair: Ms. Wang Lijuan (Independent) • Members: Dr. Jin Jian, Mr. IP Wang Hoi

2. Remuneration and Appraisal Committee • Chair: Mr. Wei Shirong (Independent) • Members: Dr. Jin Jian, Dr. Liang Bill Wenqing

3. Nomination Committee • Chair: Mr. IP Wang Hoi (Independent) • Members: Ms. Zhu Yuyu, Dr. Liang Bill Wenqing

Leadership Highlights • Dr. Liang Bill Wenqing continues as Board Chair and serves on both the Audit and Nomination Committees, underscoring active executive involvement in governance. • Independent directors chair all three key committees, concentrating oversight responsibilities among non-management members.

The announcement reinforces CF PharmTech’s commitment to maintaining a balanced governance framework aligned with market best practices.